跳至主要内容
临床试验/NCT07124130
NCT07124130招募中4 期

Parenteral Lactated Ringer's Plus Dextrose 5% vs Lactated Ringer's in Labor: A Randomized Control Trial on Maternal and Neonatal Outcomes

Eastern Virginia Medical School2 个研究点 分布在 2 个国家目标入组 158 人开始时间: 2025年9月1日最近更新:
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
158
试验地点
2
主要终点
Time from Induction Start To Delivery

研究概览

简要总结

The goal of this clinical trial is to determine which of two types of standard intravenous (IV) fluids (a combination of 5% dextrose and Lactated Ringers solution and Lactated Ringers solution alone) has a better influence on labor when inducing labor in pregnant women. The main questions it aims to answer are:

  1. Does the use of 5% dextrose and Lactated Ringers lead to a shorter labor than the use of just Lactated Ringers?
  2. Does the use of 5% dextrose and Lactated Ringers increase the risk of neonatal hypoglycemia when compared to Lactated Ringers? Participants in this trial will be randomly assigned to one of two groups: a group that receives a solution of 5% dextrose and Lactated Ringers, and a group that receives Lactated Ringers alone. Researchers will compare the outcomes of the two groups to see which IV fluid is more effective.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Nulliparous women
  • Age 18 years or older and able to provide informed consent
  • Singleton pregnancy at term
  • Induction of labor
  • Cephalic presentation
  • Unfavorable cervix (Bishop score ≤ 6)

排除标准

  • Age under 18 years
  • Involuntarily confined or detained
  • Considered as having diminished decision-making capacity
  • Spontaneous labor (cervical exam between 5-6 cm) with or without ruptured membraned
  • Favorable cervix (Bishop score >6)
  • Diabetes mellitus (both gestational and pre-gestational)
  • Structural renal disease
  • Acute or chronic kidney disease resulting in abnormal creatinine or proteinuria
  • Evidence of chorioamnionitis or non-reassuring fetal testing at the time of enrollment
  • Pyrexia (>38.0 degrees Celsius)
  • Stillbirth
  • Planned cesarean delivery
  • Women presenting with emergent circumstances for labor induction

研究组 & 干预措施

5% dextrose and Lactate Ringer

Active Comparator

Participants randomized to this arm will receive an intravenous solution of 5% dextrose and Lactate Ringer during labor.

干预措施: 5% Dextrose (D5) in Normal Saline (NS) (Drug)

5% dextrose and Lactate Ringer

Active Comparator

Participants randomized to this arm will receive an intravenous solution of 5% dextrose and Lactate Ringer during labor.

干预措施: Lactate Ringer (Drug)

Lactate Ringer only

Active Comparator

Participants randomized to this arm will receive an intravenous Lactate Ringer solution only.

干预措施: Lactate Ringer (Drug)

结局指标

主要结局

Time from Induction Start To Delivery

时间窗: From enrollment to the end of labor

次要结局

  • Type of amniotomy(From enrollment until delivery)
  • Mode of Delivery(From enrollment until delivery.)
  • Indication for cesarean delivery(From enrollment until delivery.)
  • Delivery within 12 hours of induction.(Time from induction until delivery.)
  • Delivery within 24 hours of Induction(Time of induction to time of delivery.)
  • Delivery within 36 hours of Induction(From time of induction to time of delivery.)
  • Delivery within 48 hours of Induction(From time of induction to time of delivery.)
  • Perineal Lacerations (Degree I-IV)(From time of enrollment to time of delivery.)
  • Postpartum hemorrhage(Time of enrollment to time of delivery.)
  • Blood Transfusion(From time of enrollment to hospital discharge (up to 42 days post-delivery).)
  • Isolated maternal fever(From time of enrollment to hospital discharge (up to 42 days post-delivery).)
  • Diagnosed Endometritis(From time of enrollment to hospital discharge (up to 42 days post-delivery).)
  • Wound Separation/Infection(From time of enrollment to hospital discharge (up to 42 days post-delivery).)
  • Intraamniotic Infection(From time of enrollment to hospital discharge (up to 42 days post-delivery).)
  • Venous Thromboembolism (VTE)(From time of enrollment to hospital discharge (up to 42 days post-delivery).)
  • Hysterectomy(From time of enrollment to hospital discharge (up to 42 days post-delivery).)
  • Intensive Care Unit (ICU) Admission(From time of enrollment to ICU admission (up to 42 days post-delivery).)
  • Maternal Death(From time of enrollment until maternal death (up to 42 days post-delivery).)
  • Length of hospital stay(From time of hospital admission to time of hospital discharge (up to 50 days post-delivery).)
  • Cord Prolapse(From time of enrollment to delivery.)
  • Use of Terbutaline(From time of enrollment to delivery.)
  • Placement of Intrauterine Pressure Catheter(From time of enrollment to delivery.)
  • Epidural Use(From time of enrollment to delivery.)
  • Neonatal 5- minute Apgar score <7(From time of delivery up to 1 day following delivery.)
  • Neonatal Intensive Care Unit (NICU) Admission(From time of delivery to NICU admission. Includes the entire length of neonate's hospital stay, up to 1 year following delivery.)
  • Neonatal Head Cooling Therapy(From time of delivery to time of hospital discharge. Includes the entire length of neonate's hospital stay, up to 1 year following delivery.)
  • Neonatal Length of Stay (days)(From time of delivery to time of hospital discharge. Includes the entire length of neonate's hospital stay, up to 1 year following delivery.)
  • Neonatal Severe Respiratory Distress Syndrome (RDS)(From time of delivery to hospital discharge. Includes the entire length of neonate's hospital stay, up to 1 year following delivery.)
  • Neonatal outcome composite(From time of delivery to hospital discharge. Includes the entire length of neonate's hospital stay, up to 1 year following delivery.)
  • Hypoxic-Ischemic Encephalopathy(From time of delivery to hospital discharge. Includes the entire length of neonate's hospital stay, up to 1 year following delivery.)
  • Neonatal Intraventricular Hemorrhage (Grade 3 or 4)(From time of enrollment to hospital discharge. Includes the entire length of neonate's hospital stay, up to 1 year following delivery.)
  • Arterial umbilical cord pH <7(From time of enrollment up to 1 day following delivery.)
  • Diagnosed Neonatal Necrotizing Enterocolitis(From time of delivery to time of hospital discharge. Includes the entire length of neonate's hospital stay, up to 1 year following delivery.)
  • NICU Stay >48 hours(From NICU admission to NICU discharge. Includes the entire length of neonate's hospital stay, up to 1 year following delivery.)
  • Bishop Score: Cervical Dilation, Effacement, Station, Position, Consistency(From time of enrollment to time of induction up to 1 week.)
  • Neonatal Sepsis (Culture-proven or Presumed)(From time of delivery to hospital discharge. Includes the entire length of neonate's hospital stay, up to 1 year following delivery.)
  • Neonatal Blood Transfusion(From time of delivery to time of hospital discharge. Includes the entire length of neonate's hospital stay, up to 1 year following delivery.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tetsuya Kawakita, MD

Associate Professor

Eastern Virginia Medical School

研究点 (2)

Loading locations...

相似试验